Original Papers (2002)
  1. Haradahira T.,Okauchi T.,Maeda J.,Zhang M.-R.,Kida T.,Kawabe K.,Mishina M.,Watanabe Y., Suzuki K.,Suhara T. A Positron-emitter labeled GlycineB Site Antagonist, [11C]L-703, 717, Preferentially binds to a Cerebellar NMDA receptor Subtype Consisting of GluR ε3 subunits in vivo, but not in vitro. Synapse43:131-133,2002

  2. Suhara T.,Okubo Y.,Yasuno F.,Sudo Y.,Inoue M.,Ichimiya T.,Nakashima Y.,Nakayama K., Tanada S.,Suzuki K.,Halldin C.,Farde L. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psych59:25-30,2002

  3. Zhang M.-R.,Haradahira T.,Maeda J.,Okauchi T.,Kawabe K.,Noguchi J.,Kida T., Suzuki K.,Suhara T. Syntheses and Pharmacological Evaluation of Two Potent Antagonists for Dopamine D4 Receptors: [ 11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C] methoxybenzamide. Nucl Med Biol29:233-241,2002

  4. Suhara T.,Okauchi T.,Sudo Y.,Takano A.,Kawabe K.,Maeda J.,Kapur S. Clozapine can induce high dopamine D2 receptor occupancy in vivo. Psychopharmacology160:107-112,2002

  5. Ikoma Y.,Suhara T.,Toyama H.,Ichimiya T.,Takano A.,Sudo Y.,Inoue M.,Yasuno F.,Suzuki K. Quantitative analysis for estimating binding potential of the brain serotonin transporter with [11C]McN5652. J Cereb Blood Flow Metab22:490-501,2002

  6. Ichimiya T.,Suhara T.,Sudo Y.,Okubo Y.,Nakayama K.,Nankai M.,Inoue M.,Yasuno F.,Takano A., Maeda J.,Shibuya H. Serotonin Transporter Binding in Patients with Mood Disorders: A PET Study with [11C](+)McN5652. Biol Psychiatry51:715-722,2002

  7. Zhang M.-R.,Haradahira T.,Maeda J.,Okauchi T.,Kawabe K.,Kida T.,Obayashi S.,Suzuki K.,Suhara T. Synthesis and evaluation of 3-(4-Chlorobenzyl)-8-[11C]methoxy-1,2,3,4-terahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma1 receptors. Nucl Med Biol29:469-476,2002

  8. Haradahira T.,Maeda J.,Okauchi T.,Zhang M.-R.,Hojo J.,Kida T.,Arai T., Yamamoto F.,Sasaki S.,Maeda M.,Suzuki K.,Suhara T. Synthesis,in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors. Nucl Med Biol29:517-525,2002

  9. Yamamoto M.,Suhara T.,Okubo Y,.Ichimiya T.,Sudo Y.,Inoue M.,Takano A.,Yasuno F.,Yoshikawa K.,Tanada S. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sci71:751-757,2002

  10. Yasuno F.,Hasnine A.H.,Suhara T.,Ichimiya T.,Sudo Y.,Inoue M.,Takano A.,Ou T., Ando T.,Toyama H. Template-based method for multiple volumes of interest of human brain PET images. NeuroImage 16:577-586,2002

  11. Takano A.,Suhara T.,Sudo Y.,Inoue M.,Hashimoto K.,Zhang M.-R.,Ichimiya T.,Yasuno F.,Suzuki K. Comparative evaluation of two serotonin transporter ligands in the human brain: [11C](+)McN5652 and [11C]cyanoimipramine. Eur J Nurc Med29:1289-1297,2002

  12. Nakayama T.,Suhara T.,Okubo Y.,Ichimiya T.,Yasuno F.,Maeda J.,Takano A.,Saijo T.,Suzuki K. In vivo drug action of tandospirone at 5-HR1A receptor examined using positron emission tomography and neuroendocrine response. Psychopharmacology165:37-42,2002

  13. Sassa T.,Suhara T.,Ikehira H.,Obata T.,Girard F.,Tanada S.,Okubo Y. 19F-magnetic resonance spectroscopy and chemical shift imaging for schizophrenic patients using haloperidol decanoate. Psychiatry Clin Neurosci 56:637-642,2002

  14. Zhang M.-R.,Haradahira T.,Maeda J.,Okauchi T.,Kida T.,Obayashi S.,Suzuki K.,Suhara T. Synthesis and preliminary PET study of the 5-HT 7 receptor antagonist [11C]DR4446. J label comp radiopharm 45:857-866,2002

  15. Obayashi S.,Suhara T.,Nagai Y.,Maeda J.,Hihara S.,Iriki A. Macaque prefrontal activity associated with extensive tool use. NeuroReport 13:2349-2354,2002

Original Papers (2002)